Amy L. Burroughs
CIK 1872564 · Chief Executive Officer · last filed 2026-05-29
Amy L. Burroughs is a Chief Executive Officer who has filed 19 SEC Form 4 insider transactions across 3 companies since 2021. The most recent filing, for TNYA, was dated May 29, 2026. Across all open-market trades the lifetime net is −$6.2M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $414.1K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$414.1K
3
19
-$6.17M
Holdings By Company
Recent Filings
19 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-29 | TNYA | Grant (A) | — | $0 | EDGAR |
| 2026-05-05 | Terns Pharmaceuticals, Inc. (TERN) Delisted | Mixed | −304,933 | -$16.16M | EDGAR |
| 2026-03-17 | Terns Pharmaceuticals, Inc. (TERN) Delisted | Mixed | — | -$613.4K | EDGAR |
| 2026-02-18 | Terns Pharmaceuticals, Inc. (TERN) Delisted | Mixed | — | -$503.9K | EDGAR |
| 2026-01-16 | Terns Pharmaceuticals, Inc. (TERN) Delisted | Mixed | +150,000 | -$2.23M | EDGAR |
| 2026-01-06 | Terns Pharmaceuticals, Inc. (TERN) Delisted | Mixed | +100,212 | -$2.62M | EDGAR |
| 2025-06-25 | Terns Pharmaceuticals, Inc. (TERN) Delisted | Buy (P) | +23,314 | $90.2K | EDGAR |
| 2025-05-30 | TNYA | Grant (A) | — | $0 | EDGAR |
| 2025-02-03 | Terns Pharmaceuticals, Inc. (TERN) Delisted | Mixed | +510 | $2.6K | EDGAR |
| 2024-12-09 | Terns Pharmaceuticals, Inc. (TERN) Delisted | Buy (P) | +15,450 | $110.5K | EDGAR |